These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11585357)

  • 21. Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study.
    Bergström I; Freyschuss B; Landgren BM
    Osteoporos Int; 2005 Jul; 16(7):823-8. PubMed ID: 15536539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between bone turnover markers, bone mineral density and vitamin D in Moroccan postmenopausal women].
    Elmaataoui A; Elmachtani Idrissi S; Dami A; Bouhsain S; Chabraoui L; Ouzzif Z
    Pathol Biol (Paris); 2014 Feb; 62(1):49-54. PubMed ID: 24461391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss.
    Salamone LM; Cauley JA; Zmuda J; Pasagian-Macaulay A; Epstein RS; Ferrell RE; Black DM; Kuller LH
    J Bone Miner Res; 2000 Feb; 15(2):308-14. PubMed ID: 10703933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
    Coin A; Veronese N; Bolzetta F; De Rui M; Manzato E; Sergi G
    Panminerva Med; 2012 Dec; 54(4):277-82. PubMed ID: 23123579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis and apolipoprotein E genotype in older adults: the Rancho Bernardo study.
    von Mühlen DG; Barrett-Connor E; Schneider DL; Morin PA; Parry P
    Osteoporos Int; 2001; 12(4):332-5. PubMed ID: 11420784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women.
    Chapurlat RD; Garnero P; Sornay-Rendu E; Arlot ME; Claustrat B; Delmas PD
    Osteoporos Int; 2000; 11(6):493-8. PubMed ID: 10982164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
    Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
    J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F; Nieves J; Woelfert L; Formica C; Gordon S; Shen V; Lindsay R
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical markers as predictors of bone mineral density changes after GnRH agonist treatment.
    Borderie D; Cherruau B; Dougados M; Ekindjian OG; Roux C
    Calcif Tissue Int; 1998 Jan; 62(1):21-5. PubMed ID: 9405728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss.
    MacDonald HM; McGuigan FA; New SA; Campbell MK; Golden MH; Ralston SH; Reid DM
    J Bone Miner Res; 2001 Sep; 16(9):1634-41. PubMed ID: 11547832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy.
    Balducci R; Toscano V; Pasquino AM; Mangiantini A; Municchi G; Armenise P; Terracina S; Prossomariti G; Boscherini B
    Eur J Endocrinol; 1995 Jan; 132(1):42-6. PubMed ID: 7850009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical parameters associated with low bone density in healthy men and women.
    Sherman SS; Tobin JD; Hollis BW; Gundberg CM; Roy TA; Plato CC
    J Bone Miner Res; 1992 Oct; 7(10):1123-30. PubMed ID: 1456082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus.
    Gerdhem P; Isaksson A; Akesson K; Obrant KJ
    Osteoporos Int; 2005 Dec; 16(12):1506-12. PubMed ID: 15824889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.